Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Supply Chain
Awards
Outsourcing Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Supply Chain
Awards
Outsourcing Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
epilepsy
Marketing
Filana leaves Cassava roots behind amid branch into epilepsy
Cassava has rebranded as Filana Therapeutics, shedding baggage associated with the old name as the biotech plants itself in a new therapeutic area.
Nick Paul Taylor
Mar 10, 2026 11:05am
Results for UCB's Fintepla pave way for 3rd epileptic indication
Dec 8, 2025 11:19am
SK eyes Xcopri expansion with phase 3 win in new seizure type
Sep 17, 2025 11:32am
UCB's Fintepla shows potential to treat a 3rd epilepsy disorder
Jun 27, 2025 11:28am
Takeda, Enhertu, East Asian American execs—Fierce Pharma Asia
Jan 31, 2025 8:53am
Jazz hunts for new CEO as longtime chief Cozadd eyes retirement
Dec 17, 2024 10:49am
